Aug 4, 2026 | Business, Clinical Trial Trends, Industry Trends
Financial statements show how much pharmaceutical companies spend. Clinical trial data reveals whether that investment is building future pipeline value. Introduction Financial statements tell us how much pharmaceutical companies spend. Clinical trial registries tell...
Apr 29, 2026 | Business, Market Scan
A Joint Whitepaper by Planview and Ozmosi Executive Summary Pharmaceutical portfolio strategy is entering a new era. For decades, life sciences organizations have invested heavily in internal systems to manage clinical development, allocate resources, forecast...
Oct 26, 2025 | Business, Data Analytics, Industry Trends, Market Scan, New Technology, Probability of Success
The leaders, the contenders, and the strategies for success As we approach the 4th quarter of 2025, let’s review where the pharmaceutical industry’s leading companies rank in terms of overall pipeline strength. Roche, AstraZeneca, and Bristol-Myers Squibb sit in a...
Feb 27, 2024 | Business, Chronic Disease, Diabetes, Disease Area Trends
For years, Eli Lilly’s main contributions to the Diabetes market were their insulins: fast-acting analog Humalog® and human insulin Humalin and two premix offerings in analog Humalog® Mix 50/50 and human premix Humalin 75/25. Despite a legacy category, this portfolio...
Jan 27, 2024 | Business, Data Analytics, Diabetes, Disease Area Trends
Merck’s two blockbuster diabetes products, Janumet® and Januvia®, are DPP-4 inhibitors that generated nearly $3.3 billion in Sales in 2016.3 Januvia® is especially known for its great cardiovascular safety profile, which has helped differentiate itself in its class....
